DK164108C - Derivat af humant interferon-gamma-polypeptid, rekombinant plasmid til brug ved fremstilling deraf, fremgangsmaade til fremstilling deraf og mikroorganisme indeholdende rekombinant plasmid - Google Patents

Derivat af humant interferon-gamma-polypeptid, rekombinant plasmid til brug ved fremstilling deraf, fremgangsmaade til fremstilling deraf og mikroorganisme indeholdende rekombinant plasmid

Info

Publication number
DK164108C
DK164108C DK314485A DK314485A DK164108C DK 164108 C DK164108 C DK 164108C DK 314485 A DK314485 A DK 314485A DK 314485 A DK314485 A DK 314485A DK 164108 C DK164108 C DK 164108C
Authority
DK
Denmark
Prior art keywords
recombinant plasmid
derivatives
humant
interferon
preparing
Prior art date
Application number
DK314485A
Other languages
English (en)
Other versions
DK314485A (da
DK164108B (da
DK314485D0 (da
Inventor
Seiga Itoh
Yasutoshi Takeichi
Moriyuki Sato
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=15350817&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK164108(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Publication of DK314485D0 publication Critical patent/DK314485D0/da
Publication of DK314485A publication Critical patent/DK314485A/da
Publication of DK164108B publication Critical patent/DK164108B/da
Application granted granted Critical
Publication of DK164108C publication Critical patent/DK164108C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK314485A 1984-07-11 1985-07-10 Derivat af humant interferon-gamma-polypeptid, rekombinant plasmid til brug ved fremstilling deraf, fremgangsmaade til fremstilling deraf og mikroorganisme indeholdende rekombinant plasmid DK164108C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP14395084 1984-07-11
JP14395084A JPS6124599A (ja) 1984-07-11 1984-07-11 新規ヒトインタ−フエロン−ｒポリペプチド誘導体

Publications (4)

Publication Number Publication Date
DK314485D0 DK314485D0 (da) 1985-07-10
DK314485A DK314485A (da) 1986-01-12
DK164108B DK164108B (da) 1992-05-11
DK164108C true DK164108C (da) 1992-10-12

Family

ID=15350817

Family Applications (1)

Application Number Title Priority Date Filing Date
DK314485A DK164108C (da) 1984-07-11 1985-07-10 Derivat af humant interferon-gamma-polypeptid, rekombinant plasmid til brug ved fremstilling deraf, fremgangsmaade til fremstilling deraf og mikroorganisme indeholdende rekombinant plasmid

Country Status (11)

Country Link
US (1) US4898931A (da)
EP (1) EP0170917B1 (da)
JP (1) JPS6124599A (da)
AT (1) ATE63923T1 (da)
AU (1) AU586822B2 (da)
CA (1) CA1303529C (da)
DE (2) DE3582973D1 (da)
DK (1) DK164108C (da)
ES (1) ES8609484A1 (da)
IL (1) IL75738A (da)
NO (1) NO175487C (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8334102D0 (en) * 1983-12-21 1984-02-01 Searle & Co Interferons with cysteine pattern
CA1340265C (en) * 1985-01-18 1998-12-15 Kirston E. Koths Oxidation resistant muteins
GB8619725D0 (en) * 1986-08-13 1986-09-24 Hoffmann La Roche Homogenous interferon fragments
JP2653061B2 (ja) * 1986-12-27 1997-09-10 武田薬品工業株式会社 新規ポリペプチドおよびその製造法
AT393690B (de) * 1987-10-08 1991-11-25 Hoffmann La Roche Homogene, rekombinante immun-interferonfragmente
DE3829180A1 (de) * 1988-08-29 1990-03-08 Boehringer Ingelheim Int Neues arzneimittel zur vorbeugung und behandlung von durch primaere immundefekte verursachte krankheiten
DE4036856C1 (da) * 1990-11-19 1992-05-27 Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung Ev, 8000 Muenchen, De
KR100475492B1 (ko) * 1995-01-26 2005-03-14 바이오겐 아이덱 엠에이 인코포레이티드 항종양제로서의 림프독소-α/β 복합체 및항-림프독소-β수용체 항체
DE19535853C2 (de) * 1995-09-18 1999-04-01 Fraunhofer Ges Forschung Varianten des rekombinanten humanen Interferon-gamma, Verfahren zu ihrer Herstellung und ihre Verwendung
AU782635B2 (en) * 1999-11-12 2005-08-18 Maxygen Holdings Ltd. Interferon gamma conjugates
CA2390292A1 (en) 1999-11-12 2001-05-25 Maxygen Holdings Ltd. Interferon gamma conjugates
CN1309423C (zh) 1999-11-12 2007-04-11 马克西根控股公司 干扰素γ偶联物
US6958388B2 (en) 2001-04-06 2005-10-25 Maxygen, Aps Interferon gamma polypeptide variants
US7038015B2 (en) 2001-04-06 2006-05-02 Maxygen Holdings, Ltd. Interferon gamma polypeptide variants
CA2491178A1 (en) 2002-07-03 2004-01-15 Maxygen Holdings Ltd. Full-length interferon gamma polypeptide variants
BRPI0507169A (pt) * 2004-02-02 2007-06-26 Ambrx Inc polipeptìdeos do hormÈnio de crescimento humano modificados e seu usos
AU2006255122B2 (en) * 2005-06-03 2010-10-21 Ambrx, Inc. Improved human interferon molecules and their uses
EP1991679A2 (fr) * 2006-03-08 2008-11-19 Biomethodes Variants de l'interferon- gamma humain (ifngamma)
FR2898359B1 (fr) * 2006-03-08 2011-07-15 Biomethodes Variants ameliores de l'interferon-gamma humain (ifn gamma)
MX344166B (es) 2008-02-08 2016-12-07 Ambrx Inc Leptina-polipeptidos modificados y sus usos.
WO2020028275A1 (en) * 2018-07-30 2020-02-06 The Board Of Trustees Of The Leland Stanford Junior University Interferon-gamma biased agonists

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
JPS58110548A (ja) * 1981-12-24 1983-07-01 Asahi Chem Ind Co Ltd 新規な生理活性ペプチド
US6936694B1 (en) * 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
JPH0787797B2 (ja) * 1982-05-20 1995-09-27 サントリー株式会社 ヒト・ガンマ・インタ−フエロン様ポリペプチドの製造法
US4681848A (en) * 1982-09-22 1987-07-21 Takeda Chemical Industries, Ltd. Novel peptide and use thereof
IL69851A0 (en) * 1982-09-30 1983-12-30 Japan Found Cancer Novel dna and recombinant plasmid containing the same
US4758656A (en) * 1983-12-26 1988-07-19 Kyowa Hakko Kogyo Co., Ltd. Novel human interferon-gamma polypeptide derivative
AU582574B2 (en) * 1984-04-19 1989-04-06 Hoechst Aktiengesellschaft The preparation of polypeptides having human gamma interferon activity
IL75302A0 (en) * 1984-06-06 1985-09-29 Takeda Chemical Industries Ltd Novel polypeptide and production thereof

Also Published As

Publication number Publication date
NO175487C (no) 1994-10-19
US4898931A (en) 1990-02-06
DK314485A (da) 1986-01-12
ES8609484A1 (es) 1986-09-01
AU586822B2 (en) 1989-07-27
EP0170917B1 (en) 1991-05-29
JPS6124599A (ja) 1986-02-03
AU4474985A (en) 1986-01-16
EP0170917A1 (en) 1986-02-12
DK164108B (da) 1992-05-11
NO175487B (no) 1994-07-11
DE3582973D1 (de) 1991-07-04
IL75738A (en) 1995-06-29
IL75738A0 (en) 1985-11-29
ES545052A0 (es) 1986-09-01
ATE63923T1 (de) 1991-06-15
NO852776L (no) 1986-01-13
CA1303529C (en) 1992-06-16
DK314485D0 (da) 1985-07-10
DE170917T1 (de) 1986-09-04

Similar Documents

Publication Publication Date Title
DK164108C (da) Derivat af humant interferon-gamma-polypeptid, rekombinant plasmid til brug ved fremstilling deraf, fremgangsmaade til fremstilling deraf og mikroorganisme indeholdende rekombinant plasmid
DK58789D0 (da) Proteiner med faktor viii-aktivitet, fremgangsmaade til deres fremstilling ved anvendelse af genetisk konstruerede celler og farmaceutiske kompositioner indeholdende proteinerne
FI882176A7 (fi) Menetelmä terapeuttisesti aktiivisten heterosyklisten peptidien valmistamiseksi ja niiden valmistuksessa käyttökelpoisia välituotteita
CZ738982A3 (en) Human immune interferon and derivative thereof, separated dna with sequence encoding human immune interferon, recombinant cloning vector, replicable expression vector, recombinant micro-organism or cellular culture, pharmaceutical preparation, process for preparing the human immune interferon and its use
DK161152C (da) Polypeptid med egenskaber som human beta-nervevaekstfaktor og fremgangsmaade til fremstilling deraf, dna-isolat omfattende en sekvens som koder for polypeptidet, replicerbar udtrykkelsesvektor for dna-sekvensen, rekombinant vaertscelle transformeret med vektoren, farmaceutisk praeparat indeholdende polypeptidet og fremg. der omfatter anvendelsen af polypeptidet til fremst. af et farmaceutisk praeparat
PT82834A (en) Process for preparing pharmaceutical compositions with solubilization of proteins using polymer conjugation
ATE42309T1 (de) Knockenbildungsfaktoren.
EP0201743A3 (en) Dipeptide derivatives of fatty acids, process for preparing them, pharmaceutical composition and use
EP0675136A3 (en) Antibodies to mammalian interleukin-4 and peptides useful as antigens in their production.
IL71652A (en) Non-toxinogenic vibrio cholerae mutants
DK208985A (da) Antigent praeparat og fremgangsmaade til isolering af et saadant praeparat
NO171983C (no) Fremstilling av polypeptider med human-gammainterferon-aktivitet og dna-sekvens derav
CS383091A3 (en) Novel pyridazinamine derivatives, process of their preparation and anti-viral preparations based thereon
DK0851926T3 (da) Varianter af humant rekombinant gamminterferon (rhu-IFN-gamma) med forøget termisk stabilitet
DE3061854D1 (en) Process for the preparation of interferon and culture medium composition used in it
DK0402070T3 (da) Krystallinsk r-h-GM-CSF og fremgangsmåde til fremstilling heraf
NO883261L (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
HU895788D0 (en) Process for producing peptides and medical products containing them
FI102282B1 (fi) Menetelmä O-glykosyloidun IGF-1:n valmistamiseksi
EG19937A (en) A process for preparing a novel proteins are related to lipase enzyme used as food and pharmaceutical compounds
HUT45035A (en) Process for producing thiazolone derivatives
ES2078229T3 (es) Procedimiento para la preparacion de un polipeptido similar a la motilina y su expresion.
PT87207A (pt) Process for preparing recombinant htlv-iii proteins and uses thereof
BG44029A3 (en) Method for preparing of n- dimethyl morphinanic derivatives
DK197091A (da) Fremgangsmaade til fremstilling af proteiner med fviii aktivitet og/eller fviii derivater

Legal Events

Date Code Title Description
PBP Patent lapsed